Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals Secures 180-Day Nasdaq Reprieve, Eyes Reverse Split to Maintain Listing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.441
Mkt Cap
$7.863M
52W Low
$0.162
52W High
$2.75
52W Position info
172% above low
Off High info
84% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

MGRX has more than doubled off its 52-week low of $0.162 on light trading volume (0.3× avg).

Summary

Nasdaq granted Mangoceuticals an additional 180 days to regain compliance with the minimum bid price requirement, and the company plans a reverse stock split if needed. The extension provides runway to close the pending reverse merger with Nuclea Energy.


Key Events · Legal and Risk Events · MGRX

  • Nasdaq Extension Granted

    Nasdaq granted an additional 180-day compliance period until February 1, 2027, for the minimum bid price requirement, based on the company meeting other listing standards and its intent to cure via a reverse stock split.

  • Reverse Split on the Table

    The company explicitly stated it will effect a reverse stock split if necessary to regain compliance, which would further dilute existing shareholders already facing a 96% reduction in ownership from the pending Nuclea Energy reverse merger.

  • Merger Context

    The extension comes just days after announcing a definitive business combination agreement with Nuclea Energy, a private nuclear startup, in a deal that would leave current Mangoceuticals shareholders with only 4% of the combined entity.

  • Going Concern and Cash Pressure

    The company's last 10-Q (May 2026) showed a sharp decline in cash, a growing accumulated deficit, and a going concern warning, underscoring the urgency of the merger and the listing extension.


Analysis · MGRX · Industrial Applications And Services

A critical 180-day extension from Nasdaq gives Mangoceuticals until February 1, 2027, to regain compliance with the $1.00 minimum bid price rule. The company has explicitly stated it will effect a reverse stock split if necessary to cure the deficiency. This development arrives just days after the announcement of a reverse merger with Nuclea Energy—a deal that would leave existing shareholders with only 4% of the combined company. While the extension buys time to complete the merger, the threat of a reverse split adds another layer of dilution risk for current holders.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.44 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.9M. The 52-week trading range was $0.16 to $2.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1987 info
Change: +$0.0087 (+5%) info
Market Cap: $4.332M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1987 info
Change: +$0.0087 (+5%) info
Market Cap: $4.332M info
MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.1987 info
Change: -$0.2313 (-54%) info
Market Cap: $4.332M info
MGRX
Oct 09, 2026, 4:00 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4251
Real-time Price: $0.1987 info
Change: -$0.2264 (-53%) info
Market Cap: $4.332M info
MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.1987 info
Change: -$0.212 (-52%) info
Market Cap: $4.332M info